Month: March 2017
Experimental Pathology Laboratories and WestChina-Frontier PharmaTech Form Strategic Alliance for Preclinical Services
Experimental Pathology Laboratories, Inc. (EPL), and West China-Frontier PharmaTech Co., Ltd. (WCFP) announce a Strategic Alliance to enhance Preclinical Services. This alliance is targeted to bolster the rapid growth of WCFP by specifically providing EPL’s Pathology Peer Review Services for WCFP projects that are being submitted to international regulatory agencies. WCFP is experiencing rapid growth […]
Experimental Pathology Laboratories, Aclairo Pharmaceutical Development Group, and Expedient Solutions International Form Strategic Alliance to Enhance Pathology and Regulatory Consulting Services to the Greater China Region
Experimental Pathology Laboratories, Inc. (EPL), Aclairo Pharmaceutical Development Group, Inc. (Alcairo), and Dr. Ada H.C. Kung with Expedient Solutions International (ESI) announce a new strategic alliance to enhance Preclinical Pathology and Regulatory Consulting Services to the Greater China pharmaceutical and biotechnology industry. This alliance is targeted to expand and enhance EPL, Aclairo, and ESI’s capabilities […]